A survey on the use of analgesics in cancer pain management for cancer patients at Department of Pain Control and Palliative Care, 108 Military Central Hospital

  • Nguyen Tu Son Hanoi University of Pharmacy
  • Dang Thi Thuy 108 Military Central Hospital
  • Ngo Thi Xuan Thu 108 Military Central Hospital
  • Nguyen Thi Lien Huong Hanoi University of Pharmacy
  • La Van Truong 108 Military Central Hospital
  • Nguyen Duc Trung 108 Military Central Hospital

Main Article Content

Keywords

Pain relief, cancer, palliative care

Abstract

Objective: To investigate the use of pain relievers in cancer patients and to assess pain level before and after treatment. Subject and method: Longitudinal study. 43 cancer patients participated the study. Result: There were 4 alnagesics in the study including paracetamol, diclofenac (NSAID), tramadol (weak opioid) and morphine (strong opioid). A combination of paracetamol and a weak opioid was the most use (69.8%). The proportion of patients who used adjuvants in the first regimen was 21/43 (48.8%). After the treatment, the pain score of current pain, the worst pain, the average pain, the least pain decreased significantly (p<0.05). However, some patients with severe pain needed to be prescribed more appropriately. Conclusion: Multi-modal for cancer pain management was observed in the study. Most of patients experienced pain relieve after the treatment.


              Keywords: Pain relief, cancer, palliative care.

Article Details

References

1. Krakauer Eric L (2007) Chăm sóc giảm nhẹ cho bệnh nhân HIV/AIDS và ung thư ở Việt Nam. Tài liệu tập huấn cơ bản, tr. 3-54.
2. Vương Thị Thanh Tâm (2010) Khảo sát tình hình sử dụng thuốc giảm đau trên bệnh nhân ung thư tại Trung tâm Y học Hạt nhân và Ung bướu-Bệnh viện Bạch Mai. Khóa luận tốt nghiệp Dược sĩ, Trường Đại học Dược Hà Nội, Hà Nội, tr. 10-43.
3. Bộ Y tế (2018) Dược thư quốc gia Việt Nam, lần xuất bản thứ hai. Nhà xuất bản Y học, tr. 515-517, 1400-1402.
4. Cielito C. Reyes-Gibby, Nguyen Ba Duc et al (2006) Status of cancer pain in Hanoi, Vietnam: A Hospital-Wide Survey in a Tertiary Cancer Treatment Center. Journal of Pain and Symptom Management 31: 1-13.
5. Group BMJ (2017) British National Formulary BNF 73. Royal Pharmaceutical Society: 414-445.
6. Swarm RA et al (2019) NCCN clinical practice guidelines in oncology: Adult Cancer Pain. J Natl Compr Canc Netw 17(8): 977-1007.
7. Neufeld NJ, Elnahal SM et al (2017) Cancer pain: a review of epidemiology, clinical quality and value impact. Future Oncol 13(9): 833-841.
8. Thinh DHQ, Sriraj W et al (2018) Analgesic prescription patterns and pain outcomes in Southeast Asia: Findings from the analgesic treatment of cancer pain in Southeast Asia Study. J Glob Oncol 4: 1-10.
9. Thinh DHQ, Sriraj W et al (2018) Patient and physician satisfaction with analgesic treatment: Findings from the analgesic treatment for cancer pain in Southeast Asia (ACE) study. Pain Res Manag 2193710.
10. WHO (2018) WHO Guidelines for the Pharmacological and rdiotherapeutic management of cancer pain in adults and adolescents: 1-40.
11. Ahmedzai SH, Bautista MJ et al (2019) Optimizing cancer pain management in resource-limited settings. Support Care Cancer 27(6): 2113-2124.